Detalles de la búsqueda
1.
Estimand framework: Are we asking the right questions? A case study in the solid tumor setting.
Pharm Stat
; 20(2): 324-334, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33155417
2.
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.
Oncologist
; 24(9): 1151-e817, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171735
3.
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.
BMC Cancer
; 16: 22, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26772734
4.
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib.
Cancer
; 121(9): 1405-13, 2015 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25641662
5.
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study.
Cancer Sci
; 103(8): 1502-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22537162
6.
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.
J Transl Med
; 9: 120, 2011 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21787417
7.
Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group.
Clin Genitourin Cancer
; 16(4): 298-304, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29853320
8.
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study.
Liver Cancer
; 7(2): 148-164, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29888205
9.
5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.
Cancer Manag Res
; 7: 165-73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26109878
10.
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.
J Clin Oncol
; 32(2): 76-82, 2014 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323035
11.
Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.
J Clin Oncol
; 31(32): 4067-75, 2013 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081937
12.
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.
Anticancer Res
; 32(3): 973-9, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22399619
Resultados
1 -
12
de 12
1
Próxima >
>>